Differences may also arise from the fact that the MetaboChip cohort excluded those with DM, perhaps minimizing the effect of variants that both predisposed to diabetes/obesity and increased CRP level. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.